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1. Introduction
  Schistosomiasis is a severe endemic parasitic disease 
caused by schistosomes parasitized in the human body in 
region with dense water network. It is estimated that there 
are about 700 million people under the threat of infection by 
schistosoma all over the world, and about 200 million people 
are influenced by it in Africa, South America and Asia[1,2]. 
Liver fibrosis of schistosomiasis, a kind of chronic disease, 
refers to the granuloma allergy caused by schistosome 
eggs depositing in the hepatic portal system and also 
refers to the dysplasia of liver connective tissues including 
interstitial cells and fibers caused by scar healing in the 
later period of granuloma allergic reaction[3,4]. Liver fibrosis 
can further develop into liver cirrhosis, and can also have 
invertible potency because of the regeneration capacity and 
gradual absorption of scar of liver itself[5]. Till now, many 
scholars have believed that liver fibrosis and even the early 
liver cirrhosis can be reversed[6]. Because of unique clinical 
efficacy and usability, some traditional Chinese medicines 
(TCMs) and plant drugs have been used for thousands 
of years, especially in the treatment of liver diseases[7]. 
Therefore, exploration of TCM use as the therapeutic drugs 
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and methods against liver fibrosis has been a research 
focus. For example, people have found that through anti-
inflammatory response, anti-stress reaction and anti-
proliferation and activation of hepatic stellate cells, Chinese 
herbal medicine compound preparation can reduce the liver 
fibrosis symptoms of animals, thus protecting liver function, 
reducing collagen synthesis and promoting extracellular 
matrix degradation[8-11].
  According to the characteristics of invigorating qi, 
promoting blood circulation and tonifying blood of Radix 
astragali, Salvia miltiorrhiza and Angelica sinensis, this 
research explored the efficacy of the compound composited 
by these three TCMs on liver fibrosis in rabbits with 
schistosomiasis. The pathogen treatment of praziquantel 
was also observed. The B-ultrasound diagnostic method 
was used to evaluate the efficacy. This could provide certain 
experience and reference for Chinese medicine treatment of 
liver fibrosis of schistosomiasis.
2. Materials and methods
2.1. Preparation of Chinese medicine compound mixture
  Angelica sinensis samples (smoke drying) were produced in 
Min County, Gansu province. Radix astragali was purchased 
from Changsha Jiuzhitang Pharmacy and identified by 
Institute of Chinese Materia Medica of Hunan Traditional 
Chinese Medicine Academy. Salvia miltiorrhiza was 
purchased from Beijing Tongrentang Pharmacy, and the 
Danshen tablet was crushed and then was screened by 40-
mesh screen. The compound of Radix astragali and salvia 
miltiorrhiza was prepared according to 1:1 compatibility; 
the compound of Radix astragali and Angelica sinensis was 
prepared according to 1:0.2 compatibility; the compound of 
Radix astragali, Salvia miltiorrhiza and Angelica sinensis 
was prepared according to 1:1:0.2 compatibility. These three 
kinds of Chinese medicines were crushed and screened 
by 40-mesh screen. Appropriate amount of Chinese 
medicine powder was prepared according to the previous 
ratio, extracted by alcohol/water, concentrated, and finally 
made into liquid medicine with concentration of 5 g/mL 
(concentration of Radix astragali).
 
2.2. Establishment of animal model[12]
 Twenty-four male New Zealand rabbits weighted about 
2.5 kg were selected. Fifty positive oncomelanias infected 
by Schistosoma japonicum shed cercarie in 150 mL flask. 
After full cercarie shedding, each rabbit was infected by 100 
Schistosoma japonicum cercarie through skin of abdomen. 
Then the experimental animals were set at the room 
temperature in different cages, and fed in the experimental 
conditions of ordinary animals. From the 13th week after 
schistosoma infection, B-ultrasound examination of the 
liver was performed every week, the ultrasonography of 
liver fibrosis of schistosomiasis was obtained, and then liver 
fibrosis of schistosomiasis was confirmed. This research 
was approved by Ethics Committee of The Military General 
Hospital of Beijing PLA.
2.3. Animal grouping and treatment
  Eighteen weeks after the infection, 24 experimental rabbits 
were randomly divided into four groups. Rabbits in group 
A were given etiological treatment of praziquantel and 
administered 300 mg/kg praziquantel every day; Group 
B was treated by mixture of Radix astragali and Salvia 
miltiorrhiza + praziquantel, and administered 1.67 mL/kg 
mixture of Radix astragali and Salvia miltiorrhiza + 300 mg/
kg praziquantel every day; Group C was treated by mixture 
of Radix astragali and Angelica sinensis + praziquantel, 
and administered 1.67 mL/kg mixture of Radix astragali 
and Angelica sinensis + 300 mg/kg praziquantel every day; 
Group D was treated by mixture of Radix astragali, Salvia 
miltiorrhiza and Angelica sinensis + praziquantel, and 
administered by 1.67 mL/kg mixture of Radix astragali, 
Salvia miltiorrhiza and Angelica sinensis + 300 mg/kg 
praziquantel every day.
2.4. Indexes observation
 B-ultrasound examination was performed eighteen weeks 
after schistosoma infection (before treatment) and ten weeks 
after administration of drugs, and the changes of liver 
ultrasound was observed, according to the examination 
method established by TDR Schistosomiasis Ultrasonic 
Diagnosis Advisory Council hosted by WHO in 1990[13]. 
Siemens Adam ultrasound diagnostic apparatus was used 
to show the liver anatomic images. The liver and spleen 
parenchyma and the coating were mainly observed, and 
each lead wire diameter of liver and the inner diameter 
value of PV were measured. Effective criterion: the fish scale 
or network structure of liver parenchyma disappeared and 
changed into spot thickening type. Ultrasound diagnosis of 
schistosomiasis liver cirrhosis: the changes of liver cirrhosis 
were classified into 0-3 degrees based on literatures.
  Serological detection was performed eighteen weeks after 
schistosoma infection (before treatment) and ten weeks 
after administration of drugs. A total of 4-5 mL blood was 
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collected from each rabbit’s auricular vein, and the serum 
was separated immediately for later use. Liver function 
indexes included alanine aminotransferase (ALT), total 
bilirubin (TBIL) and albumin (ALB), which were detected by 
Reitman-Frankel method, biuret method and bromocresol 
green method, respectively. Liver fibrosis indexes included 
hyaluronic acid (HA), laminin (LN), type III procollagen (PC 
栿) and type 桇 collagen (桇-C), which were detected by 
radioimmunoassay. All reagent kits were provided by Beijing 
Zhongshan Golden Bridge Co. Ltd.
2.5 Statistical analysis
  SPSS16.0 software was used for data analysis and 
processing. Measurement data were expressed by mean暲
SD. Comparison of experimental data in each group before 
and after treatment used paired t-test. Difference was 
statistically significant when P<0.05.
3. Results
3.1. Changes of liver size and PV inner diameter of rabbits 
before and after treatment 
  Comparison of B-ultrasound examination results sixteen 
weeks after administration of drugs and before it indicated 
that the treatment in group B, C and D had certain 
efficacy, and the efficacy of group D was the best. The four 
measurement values in group D were all significant (P<0.05, 
Table 1).
Table 1 
Liver size of rabbits before and after treatment of Chinese traditional 
compound medicines with different formulas (mm).
Group (n=6) Long
diameter
Width Transverse 
diameter
P V  i n n e r 
diameter
Group A before 57.9暲5.1 38.2暲4.6 70.6暲7.3 3.9暲0.6
after 60.7暲5.6 51.1暲10.8 72.8暲1.5 4.1暲0.7
t value 1.2 2.0 1.8 0.6
P value >0.05 >0.05 >0.05 >0.05
Group B before 58.1暲5.6 39.8暲5.0 70.2暲6.8 3.9暲0.7
after 49.7暲7.2 36.4暲4.3 58.7暲8.6 3.1暲0.6
t value 0.9 0.5 2.7 2.7
P value >0.05 >0.05 <0.05 <0.05
Group C before 57.6暲4.8 40.0暲4.9 69.5暲6.9 3.8暲0.5
after 50.8暲6.3 33.7暲5.2 58.1暲5.7 3.0暲0.5
t value 0.7 3.1 3.5 2.8
P value >0.05 <0.05 <0.05 <0.05
Group D before 57.4暲5.5 39.6暲5.0 69.7暲6.7 3.9暲0.8
after 48.2暲4.1 30.2暲5.7 57.4暲6.3 2.8暲0.5
t value 2.6 2.9 3.2 3.7
P value <0.05 <0.05 <0.05 <0.05
3.2. Liver parenchyma echo of rabbits before and after 
treatment
  The ultrasonograms of six rabbits in group A before 
administration of drugs showed small reticulation, which 
developed into large reticulation for four rabbits after 
administration of drugs and which was preserved for two 
rabbits. The liver parenchyma of six rabbits in group B 
before administration of drugs showed small reticulation, 
which developed into spot thickening for two rabbits 
sixteen weeks after administration of drugs and which was 
preserved for four rabbits. The liver parenchyma echo of six 
rabbits in group C before administration of drugs showed 
small reticulation, which developed into spot thickening for 
four rabbits sixteen weeks after administration of drugs and 
which was preserved for two rabbits. The liver parenchyma 
of six rabbits in group D before administration of drugs 
showed small reticulation, which developed into spot 
thickening for all rabbits sixteen weeks after administration 
of drugs.
 
3.3. Serum liver function indexes in each group before and 
after treatment
  The changes of serum liver function indexes and liver 
fibrosis indexes in each group before and after treatment 
were shown in Table 2 and 3. Table 2 showed that 
concentrations of ALT, TBIL and ALB in group A, B and C 
decreased, but ALB concentration in these three groups 
did not change significantly (P>0.05). The differences of 
concentrations of ALT, TBIL and ALB in group D were 
significant (P<0.05). Table 3 showed that the differences of 
the four indexes in group C and D was significant (P<0.05), 
and the concentration of HA in group B was more significant 
than that in group A (P<0.05).
Table 2
Serum liver function indexes in each group before and after treatment.
Group (n=6) ALT (U/L) TBIL (mmol/L) ALB (g/L)
Group A before 60.8暲11.1 2.5暲1.2 35.9暲2.1
after 55.9暲10.2 2.0暲0.6 38.4暲2.7
t value 2.2 2.8 0.5
P value >0.05 <0.05 >0.05
Group B before 61.2暲10.5 2.4暲1.0 35.1暲1.8
after 54.2暲7.8 1.8暲0.8 38.5暲3.4
t value 1.2 2.9 0.6
P value >0.05 <0.05 >0.05
Group C before 60.7暲10.6 2.3暲0.9 35.4暲2.0
after 52.1暲8.3 1.2暲0.4 39.7暲2.7
t value 2.9 3.7 2.1
P value <0.05 <0.05 >0.05
Group D before 61.3暲11.7 2.4暲1.0 35.6暲2.2
after 45.3暲8.5 0.8暲0.5 41.8暲3.0
t value 4.5 5.7 2.8
P value <0.05 <0.05 <0.05
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Table 3
Liver fibrosis indexes in each group before and after treatment (n=6).
Group HA (mg/L) LN( mg/L) PC 栿 
(毺g/L)
桇-C 
(毺g/L)
Group A before 320.8暲55.7 97.3暲28.7 41.5暲17.4 29.1暲8.0
after 258.7暲60.8 80.4暲14.6 37.1暲7.0 27.5暲8.6
t value 2.4 2.6 0.8 0.9
P value >0.05 <0.05 >0.05 >0.05
Group B before 322.4暲60.2 94.7暲26.2 40.3暲15.9 29.4暲8.6
after 231.3暲54.2 73.2暲12.3 33.7暲6.4 25.3暲7.6
t value 2.7 3.3 2.5 2.4
P value <0.05 <0.05 >0.05 >0.05
Group C before 316.7暲56.8 96.5暲27.1 42.7暲16.1 28.3暲7.8
after 167.5暲47.6 65.7暲11.6 30.2暲6.5 22.4暲6.3
t value 4.1 5.1 3.1 2.9
P value <0.05 <0.05 <0.05 <0.05
Group D before 321.2暲58.4 98.1暲25.4 39.7暲15.4 27.5暲6.9
after 114.6暲28.5 55.9暲9.4 26.0暲6.8 20.4暲7.2
t value 6.7 6.4 4.2
P value <0.05 <0.05 <0.05 <0.05
4. Discussion
   Schistosomiasis japonica is caused by eggs which get 
into liver along with blood and block intrahepatic veins. 
The growth and death of eggs can cause tissue injuries, 
form egg granuloma, and then cause hyperplasia of fibrous 
tissue, which lead to fiber occlusive diseases. The lesions 
distinctively reflect in the dense echo area along the portal 
vein, which has been verified by liver biopsy[14-17]. The 
early diagnosis and treatment of liver fibrosis play an 
important role in blocking the whole development chain 
of liver disease, therefore a direct effective diagnostic 
method is significant for early detection of this disease[18-22]. 
Ultrasonography is an effective noninvasive ultrasonographic 
method which can directly check the pathological changes 
of host caused by schistosoma[6,23-26]. It is generally believed 
that after appearance of liver fibrosis of rabbit infected with 
schistosoma, the ultrasonographic features expressed as 
increase of liver volume, thickening and strengthening of 
liver parenchyma spots, uneven strength of liver parenchyma 
echo, and “reticular” structure formed by fine light bands 
for most cases[27]. Ultrasound images can be used as a 
good parameter reflecting the degree of infection, so liver 
ultrasound can be an effective method for understanding 
and monitoring of liver injury degree caused by Schistosoma 
japonicum[28]. Results of this research showed that after 
successful modeling of liver fibrosis, the liver ultrasound 
images of rabbits expressed as small reticulation. After 
treatment of different medicines, the features of ultrasound 
images changed a lot, which indicated that ultrasonic 
diagnosis had certain value and function in early detection 
and prevention of schistosomiasis.
  TCM believes that the pathological features of 
schistosomiasis are liver meridian obstruction and stagnation 
of qi and blood, and the treatment should focus on promoting 
blood circulation by removing blood stasis, combined with 
reinforcing qi and nourishing blood and liver[29]. Based 
on the practice and theory of Chinese medicine treatment 
of schistosomiasis, this research used multiple kinds of 
compound Chinese medicine preparation cooperated with 
conventional etiology method to treat this disease. Based 
on the effect of invigorating qi, promoting blood circulation 
and enriching blood of Radix astragali, Salvia miltiorrhiza 
and Angelica sinensis respectively, researchers prepared 
three kinds of compound Chinese medicines according to 
traditional treatment method and compatibility proportion, 
which was cooperated with praziquantel treatment and 
had certain efficacy. Results of this study showed that 
the curative effect of compound Chinese medicines + 
praziquantel was better than that of praziquantel treatment, 
and the effect was most obvious when using the prescription 
of Radix astragali, Salvia miltiorrhiza and Angelica sinensis 
+ praziquantel. He et al[30] affirmed that the compound of 
Radix astragali, Salvia miltiorrhiza and Angelica sinensis 
had curative effect on liver fibrosis of schistosomiasis in 
rabbits. The changes of serum liver function and liver 
fibrosis indexes also supported this, which indicated that 
the compound of Radix astragali, Salvia miltiorrhiza and 
Angelica sinensis had good function of anti fibrosis. Results 
of B-ultrasound examination were consistent with it.
  The curative effect of treatment of Chinese medicine 
compound combined with conventional medicine 
(praziquantel) on liver fibrosis of schistosomiasis is better 
than single Western medicine liver treatment. It has 
advantages such as rapid reversal of fibrosis degree, less 
adverse reaction of drug compatibility and low price, and 
this is a safe, effective and economic method for treatment 
of liver fibrosis of schistosomiasis, owning a high clinical 
application value.
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